TABLE 2.
Number of viable M. tuberculosis organisms recovered following 6, 8, or 10 weeks of RLZ-INH or RLZ-INH-PZA treatmenta
Duration (wk) | Mean ± SD log no. of CFU in spleens
|
Mean ± SD log no. of CFU in lungs
|
||||
---|---|---|---|---|---|---|
Control | RLZ-INH | RLZ-INH-PZA | Control | RLZ-INH | RLZ-INH-PZA | |
0b | 7.12 ± 0.27 (8/8)c | 6.45 ± 0.44 (8/8) | ||||
6 | 6.01 ± 0.81 (8/8) | 0.77 ± 0.40 (3/8) | 0.85 (1/8) | 7.19 ± 0.29 (8/8) | 0 (0/8) | 0.30 ± 0.00 (2/8) |
8 | 0 (0/8) | 0 (0/8) | 0 (0/8) | 0 (0/8) | ||
10 | 0 (0/8) | 0 (0/8) | 0 (0/8) | 0 (0/8) | ||
6 + obsd | 2.69 ± 0.87 (8/8) | 3.27 ± 0.12 (5/8) | 2.60 ± 0.49 (3/8) | 3.43 ± 0.00 (2/8) | ||
8 + obs | 3.31 ± 0.14 (5/8) | 2.08 ± 0.00 (3/8) | 0 (0/8) | 0 (0/8) | ||
10 + obs | 0 (0/8) | 0 (0/8) | 0 (0/8) | 0 (0/8) |
Groups treated in parallel were maintained to observe regrowth. The mean log number of CFU was calculated for mice in which growth occurred.
Week 0 represents the beginning of treatment (1 week postinfection).
The values in parentheses represent the number of mice per group (eight per group) in which viable M. tuberculosis was detected/total number of mice in the group.
Three-month observation (obs) phase.